Endoscopy
Endoscopy
Audio Summaries
Every issue of Endoscopy moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Endoscopy.
When endoscopy is not required: reducing low value care for more sustainable endoscopy - European Society of Gastrointestinal Endoscopy (ESGE) Position Statement Update 2026 recycling ESGE published guidelines and position statements.
Nov 19, 2026
This ESGE Position Statement update consolidates existing ESGE guideline recommendations into a practical framework identifying when gastrointestinal endoscopy is not required, covering upper endoscopy, colonoscopy, EUS, ERCP, capsule endoscopy, and therapeutic procedures. The authors ask when endoscopy can be safely avoided across screening, surveillance, diagnosis, and therapy, and organize the answer into four scenarios (e.g., no meaningful benefit from screening, no added value from repeat surveillance, sufficient noninvasive alternatives, or no outcome gain over conservative management). The overarching goal is to reduce low-value procedures to improve patient safety, resource use, and the environmental footprint of endoscopy.
Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial.
Nov 16, 2026
This multicenter randomized trial asked whether fully covered metal stents anchored with an external plastic stent (FCSEMS-EPS) reduce biliary stent dysfunction compared with uncovered metal stents (USEMS) in patients with unresectable distal malignant biliary obstruction. In 99 analyzed patients followed for 12 months, stent dysfunction was less frequent with FCSEMS-EPS (27.1% vs. 49.0%; subdistribution HR 0.44), with no difference in procedure-related adverse events or overall survival. The authors conclude that FCSEMS-EPS is an effective and safe option for long-term biliary drainage in this setting.
Phase I Trial of Liquid Nitrogen Spray Cryotherapy concurrent with neoadjuvant chemoradiation for Locally Advanced Esophageal Cancer: Dose Escalation and Long-Term Overall Survival.
Nov 10, 2026
This phase 1 "3+3" dose-escalation trial asked whether liquid nitrogen spray cryotherapy (LNSC) given before and during neoadjuvant chemoradiation is safe for locally advanced esophageal cancer. No grade 2 or 3 treatment-related adverse events occurred, the maximum tolerated dose was 3 sessions (2 before and 1 during chemoradiation), and 70% of patients achieved complete clinical response, with 40% overall survival at a median follow-up of 36 months. The authors conclude that the regimen is safe and promising enough to justify a phase 2 trial, though the small sample size (n=13) limits these conclusions.
Mucosal abnormalities as key predictive factors of colorectal cancer in ulcerative colitis.
Nov 9, 2026
This population-based case-cohort study of Scandinavian ulcerative colitis patients asked what factors best predict colorectal cancer risk, including disease extent, inflammation severity, and treatment. The authors found that pancolitis roughly doubled CRC risk compared with proctitis, and that inflammation severity was not clearly associated with risk, while low-grade dysplasia and adenomas were the strongest predictors (adenomas HR 9.8). Because mucosal abnormalities outweighed disease extent and inflammation, the authors conclude that current endoscopic surveillance recommendations may need reconsideration.
Declining Cost-Effectiveness of Gastric Cancer Screening Over a Decade: A Cohort Modelling Study.
Nov 4, 2026
This study asks whether Korea's National Cancer Screening Program for gastric cancer remained cost-effective as disease incidence, costs, and population risk changed between 2012 and 2022. Using two structurally identical state-transition models parameterized with each period's conditions, the authors found that the incremental cost-utility ratio rose from KRW 9.62 million/QALY to KRW 48.62 million/QALY, pushing net monetary benefit near zero by 2025 prices at a KRW 50 million/QALY threshold. The decline was driven mainly by a shift in screen-detected findings toward lower-risk non-adenomatous lesions and higher costs, and it was markedly worse for women (KRW 84.37 million/QALY) than for men (KRW 28.20 million/QALY), supporting periodic reassessment and differentiated screening strategies.
Efficacy of Endoscopic Hand Suturing for Prevention of Adverse Events After Gastric Endoscopic Submucosal Dissection: A Multicenter Propensity Score-Matched Study.
Nov 2, 2026
This multicenter propensity score-matched study asked whether endoscopic hand suturing (EHS) of gastric ESD ulcers reduces post-ESD adverse events, particularly delayed bleeding and perforation, compared with non-EHS controls. In 123 EHS patients versus 369 matched controls, EHS was associated with a lower overall adverse event rate (1.6% vs. 8.9%, P < 0.01), driven mainly by reduced delayed bleeding, and complete closure was achieved in 94.7% of procedures. Operators' complete closure rates approached 100% after about 25 cases, suggesting that EHS is safe and effective with experience, though the study is retrospective and its findings require confirmation in prospective trials.
Endoscopic ultrasound in hepatology: A European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review.
Oct 23, 2026
This ESGE technical review asks how EUS-guided techniques should be selectively used in hepatology and portal hypertension, given heterogeneous practice and evidence quality. Using a literature search through April 2026 and GRADE grading, the authors issued eight statements supporting EUS-guided shear wave elastography, contrast-enhanced EUS, EUS-guided liver biopsy, and portal pressure gradient measurement as complementary options in selected patients and expert centers, and EUS-guided gastric varix treatment as an alternative to direct injection where expertise exists. Portal vein sampling for liquid biopsy remains investigational, and the authors conclude that standardized techniques, training, consistent outcome definitions, and prospective comparative studies are needed for wider adoption.
Cold versus hot snare endoscopic mucosal resection for 10-19-mm nonpedunculated colorectal polyps: a multicenter randomized trial.
Oct 23, 2026
This multicenter randomized trial asked whether cold snare EMR is noninferior to hot snare EMR for histologically complete resection of 10-19-mm nonpedunculated colorectal polyps. In 233 polyps, complete resection was 90.4% with cold versus 93.2% with hot snare (difference -2.7%, 95% CI -9.8 to 4.3), meeting the noninferiority criterion, though cold snare caused more intraprocedural bleeding (19.1% vs. 3.4%) and noninferiority was not shown for 15-19-mm polyps. The authors conclude that cold snare EMR is a noninferior option overall, but its suitability for the larger 15-19-mm lesions remains uncertain.
Reconstructive Endoscopic Suturing for Defect Closure After Large ≥90% Circumferential Colorectal Endoscopic Submucosal Dissection.
Oct 22, 2026
The authors aimed to evaluate the feasibility and clinical outcomes of a reconstructive endoscopic suturing technique for defect closure following large circumferential colorectal endoscopic submucosal dissection (ESD). Their study found that this suturing method was technically successful and safe, with no adverse events or symptomatic strictures observed in the sutured group, suggesting a potential strategy to mitigate stricture risk in high-risk patients. The findings indicate the need for further multicenter validation to confirm these promising results.
Predictors of clinical success in endoscopic ultrasound-guided drainage of postoperative pancreatic fluid collections.
Oct 16, 2026
This multicenter retrospective cohort study of 265 patients examined which factors predict clinical success of EUS-guided drainage for postoperative pancreatic fluid collections. Clinical success was achieved in 73% of patients, and distal pancreatectomy, compared with pancreaticoduodenectomy, was independently associated with lower odds of success (OR 0.53) and a higher rate of reintervention. The authors conclude that EUS-guided drainage is effective and safe at expert centers, with distal pancreatectomy linked to a more complex treatment course.
